This site uses cookies to enhance your user experience. By continuing to use this site you are agreeing to our COOKIE POLICY.

In this interview, Dr. Christian Schafmeister discusses the structural advantages of Spiroligomer molecules, their ability to ...

Two key advances in the 1980s — genome sequencing and structure-based drug design ... Importantly, for HCV, combination of antiviral drugs with immunomodulatory interferons may eradicate ...

Back in 2021, at the height of the pandemic, scientists at Pfizer revealed the development of a novel antiviral molecule, ...

Many antiviral drugs work by inhibiting viral RNA polymerase ... However, without a clear understanding of the Nipah virus ...

Using their model, they've built a detailed picture of Nsp2—not just as a single rigid structure ... tools that help design antiviral drugs as efficiently as possible could save countless ...

Antiviral drug development is now progressing at the pace antibiotics were 30 years ago. At present, there are some 60 antiviral drug preparations that have been approved by the US FDA ...

What strides have scientists made in developing vaccines and antiviral drugs to treat and protect people from dengue infections? Vaccines are an important way to protect people from viral infections.

An alternative to Paxlovid, the only antiviral pills approved by the US Food and Drug Administration to treat COVID-19, is on the horizon. Pfizer—the maker of Paxlovid—has begun Phase 3 ...